Bolt Biotherapeutics (BOLT) Depreciation and Depletion (2020 - 2026)
Bolt Biotherapeutics' Depreciation and Depletion history spans 7 years, with the latest figure at $200000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 50.0% to $200000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 million, a 35.29% decrease, with the full-year FY2025 number at $1.3 million, down 27.78% from a year prior.
- Depreciation and Depletion hit $200000.0 in Q1 2026 for Bolt Biotherapeutics, down from $300000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for BOLT hit a ceiling of $1.8 million in Q1 2024 and a floor of $200000.0 in Q1 2026.
- Historically, Depreciation and Depletion has averaged $482352.9 across 5 years, with a median of $400000.0 in 2022.
- Biggest five-year swings in Depreciation and Depletion: skyrocketed 260.0% in 2024 and later crashed 77.78% in 2025.
- Tracing BOLT's Depreciation and Depletion over 5 years: stood at $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then decreased by 20.0% to $400000.0 in 2024, then fell by 25.0% to $300000.0 in 2025, then tumbled by 33.33% to $200000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for BOLT at $200000.0 in Q1 2026, $300000.0 in Q4 2025, and $300000.0 in Q3 2025.